The International Liver Congress 2015

The International Liver Congress 2015 | EASL 2015

At the 2015 International Liver Congress, "scientific and medical experts from a broad range of fields including hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology and virology, pharmacology, pathology, radiology and imaging, come together from around the world to learn about the latest in liver research."

Conference Coverages

Q&A with Georgios Grammatikos, MD: Mass Spectrometry as Lipid ID'ing Method of The Future
Q&A with Georgios Grammatikos, MD: Mass Spectrometry as Lipid ID'ing Method of The Future VIDEO
Georgios Grammatikos, MD, commented at The International Liver Congress 2015 in Vienna, Austria, "We do think in liver diseases we show the opening of this topic in chronic hepatopathy and we do believe mass spectrometric methods -- in order to identify the levels of single lipids-- as one method of the future."
Hepatitis C: Drug Prices, Lack of Testing are Challenges
Despite the wealth of choices physicians have in finding drugs to treat hepatitis C infection, two challenges remain in eradicating the disease-price and lack of global screening for the virus.
Research Tactics: Never Over Interpret VIDEO
Lise Lotte Gluud, MD, DmSc, shared some of the best practices she and her colleagues learned through their own research at The International Liver Congress 2015 Vienna, Austria.
Damage to the Hepatic Antioxidant System VIDEO
Video Interview: Vinood Patel, PhD, PGCHE, fHEA, FRSC, University of Westminster, London, UK, discussed his hope for hepatologists to better understand the mechanisms that lead from fatty liver to steatohepatitis and subsequently from steatohepatitis to cirrhosis at The International Liver Congress 2015.
Liver Cancer Target Found
Researchers believe they have found a novel therapeutic to target a growth factor pathway that plays a role in liver cancer.
New Drug for Nonalcoholic Steatohepatitis
Another investigational diabetes drug appears to have promise for patients with nonalcoholic steatohepatitis, researchers reported at the International Liver Congress in Vienna, Austria.
Hepatitis C: Testing Has a Long Way to Go
The explosion in new drugs to treat hepatitis C is leading to predictions the viral infection will no longer be a major health problem. But before that can happen, much has to be done in the realm of public health, researchers said April 25 at the International Liver Congress in Vienna, Austria.
Alcohol Use Predicts Hepatitis C Deaths
In addition to injection drug use, alcohol consumption puts people at risk of dying from hepatitis C infection by increasing the severity of the disease. A French research study spells out the risks.
Weaning Transplant Patients from Immunosuppressive Drugs
The assumption used to be that after a liver transplant patients would need to take immunosuppressive drugs for years, even for life. A team of German researchers say that for about half of adult patients, that is no longer true.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$